Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Perioperative Management of Hemophilia a Using Recombinant Factor VIII in Patients Undergoing Major or Minor Surgery

Atsushi Okamoto, MD, Kenta Yamamoto, Go Eguchi, Yoshitaka Kanai, Terufumi Yamaguchi, Yasuhiro Maeda, MD PhD

Blood (2018) 132 (Supplement 1): 5082.

https://doi.org/10.1182/blood-2018-99-115755

Published: 2018

Journal Articles

MDS/Secondary AML Associated with Type I Gaucher Disease

Atsushi Okamoto, MD, Kenta Yamamoto, Go Eguchi, Yoshitaka Kanai, Terufumi Yamaguchi, Yasuhiro Maeda, MD PhD

Blood (2018) 132 (Supplement 1): 5193.

https://doi.org/10.1182/blood-2018-99-116058

Published: 2018

Journal Articles

Molecular Mechanism for Synergistic Anti-Leukemic Activity of Tyrosine Kinase Inhibitors and Glucocorticoids Against Ph+ALL

Meixian Huang, MD, Takeshi Inukai, MD, PhD, Keiko Kagami, BD, Masako Abe, BD, Tamao Shinohara, MD, Atsushi Watanabe, MD PhD, Koshi Akahane, MD PhD, Shinpei Somazu, MD, Hiroko Oshiro, MD PhD, Kumiko Goi, MD PhD, Yasuhiro Maeda, MD PhD, Seiichi Okabe, MD PhD, Shinya Kimura, MD, PhD, Kanji Sugita, MD, PhD

Blood (2016) 128 (22): 1059.

https://doi.org/10.1182/blood.V128.22.1059.1059

Published: 2016

Journal Articles

BCR-ABL Regulates Death Receptor Expression for TNF-Related Apoptosis-Inducing Ligand (TRAIL) in Philadelphia Chromosome-Positive Leukemia

Itaru Kuroda, MD, PhD, Takeshi Inukai, MD, PhD, Xiaochun Zhang, MD, PhD, Jiro Kikuchi, Yusuke Furukawa, Atsushi Nemoto, MD, PhD, Koshi Akahane, MD, PhD, Kinuko Hirose, MD, PhD, Hiroko Honna- Oshiro, MD, PhD, Kumiko Goi, MD, PhD, Keiko Kagami, Hideo Yagita, PhD, Tetsuzo Tauchi, M.D., Yasuhiro Maeda, MD, PhD, Kanji Sugita, MD, PhD

Blood (2011) 118 (21): 2740.

https://doi.org/10.1182/blood.V118.21.2740.2740

Published: 2011

Journal Articles

PD0332991, a CDK4/6 Inhibitor, Has An Anti-Leukemic Activity Against Ph + Leukemia with T315I Mutation in Bcr-Abl; In Vivo Analysis Using Xenograft Mice Model

Satoshi Saida, MD, Itaru Kato, MD, Takeshi Inukai, MD, PhD, Atsushi Nemoto, MD, PhD, Kanji Sugita, MD, PhD, Yasuhiro Maeda, MD, PhD, Akira Niwa, MD, PhD, Ken-ichiro Watanabe, MD, PhD, Tatsutoshi Nakahata, MD, PhD, Toshio Heike, MD, PhD

Blood (2011) 118 (21): 2577.

https://doi.org/10.1182/blood.V118.21.2577.2577

Published: 2011

Journal Articles

Discontinuation of Imatinib in Japanese Patients with Chronic Myeloid Leukemia,

Naoto Takahashi, MD, PhD, Taiichi Kyo, MD, Yasuhiro Maeda, MD, PhD, Takashi Sugihara, MD, PhD, Kensuke Usuki, MD, Tatsuya Kawaguchi, MD, PhD, Noriko Usui, MD, Shinichiro Okamoto, MD, PhD, Yokiko Ohe, MD, Shigeki Ohtake, MD, PhD, Kunio Kitamura, Masahide Yamamoto, MD, Hirofumi Teshima, MD, Toshiko Motoji, MD, PhD, Toshiharu Tamaki, MD, Kenichi Sawada, MD, PhD, Kazuma Ohyashiki, MD, PhD

Blood (2011) 118 (21): 3759.

https://doi.org/10.1182/blood.V118.21.3759.3759

Published: 2011

Journal Articles

Increased NK Cells and Decreased CD3 + CD8 + CD62L + T Cells in CML Patients Who Sustained Complete Molecular Remission After Discontinuation of Imatinib

Kazuma Ohyashiki, MD, PhD, Sei-ichiro Katagiri, MD, Tetsuzo Tauchi, MD, PhD, Junko H Ohyashiki, MD, PhD, Yasuhiro Maeda, MD, PhD, Itaru Matsumura, MD, PhD, Taiichi Kyo, MD

Blood (2011) 118 (21): 1697.

https://doi.org/10.1182/blood.V118.21.1697.1697

Published: 2011

Journal Articles

PD0332991, a CDK4/6 Inhibitor, Has An Anti-Leukemic Activity Against Lymphoid Crisis of CML and Ph+ALL Even with T315I Mutation in BCR-Abl; in Vitro Analysis

Atsushi Nemoto, MD, PhD, Takeshi Inukai, MD, PhD, Koshi Akahane, MD, PhD, Hiroko Honna- Oshiro, MD, PhD, Kumiko Goi, MD, PhD, Keiko Kagami, Yasuhiro Maeda, MD, PhD, Tetsuzo Tauchi, M.D., Shinya Kimura, MD, PhD, Kanji Sugita, MD, PhD

Blood (2011) 118 (21): 1511.

https://doi.org/10.1182/blood.V118.21.1511.1511

Published: 2011

Journal Articles

Outcome by Treatment Including An Intensified Consolidation Program with Dose-Escalated Doxorubicin for Newly Diagnosed Acute Lymphoblastic Leukemia (ALL): A Study by the Japan Adult Leukemia Study Group (JALSG ALL97 study).

Itsuro Jinnai, MD, Tohru Sakura, MD, Motohiro Tsuzuki, MD, Yasuhiro Maeda, MD, PhD, Noriko Usui, MD, Masayuki Kato, MD, Hirokazu Okumura, MD, PhD, Yasunori Ueda, MD, Yuji Kishimoto, MD, Fumiharu Yagasaki, MD, Jin Takeuchi, MD, Masako Iwanaga, MD, Yasushi Miyazaki, MD, Shuichi Miyawaki, MD, Kazunori Ohnishi, MD, PhD, Tomoki Naoe, MD, Ph.D., Ryuzo Ohno, MD

Blood (2009) 114 (22): 4334.

https://doi.org/10.1182/blood.V114.22.4334.4334

Published: 2009

Journal Articles

Effects of Anti-Retroviral Drugs to Expression of Cell Surface Adhesion Molecules and Hypermutation of Immunoglobulin Heavy Chain Variable Gene of HIV-Related Lymphoma

Atsushi Sasakawa, Yasuhiro Maeda, MD, PhD, Chikara Hirase, Akihisa Kanamaru

Blood (2008) 112 (11): 5280.

https://doi.org/10.1182/blood.V112.11.5280.5280

Published: 2008

Journal Articles

Clinical Efficacy of ATRA for Adult T-Cell Leukemia

Yasuhiro Maeda, MD, PhD, Terufumi Yamaguchi, Chikara Hirase, Akihisa Kanamaru

Blood (2008) 112 (11): 4985.

https://doi.org/10.1182/blood.V112.11.4985.4985

Published: 2008

Journal Articles

Possible Eradication of Minimal Residual Disease in Acute Leukemia.

Yasuki Hijikata, MD, Yasuhiro Maeda, MD, PhD, Terufumi Yamaguchi, MD, Miyako Tanaka, MD, Chikara Hirase, MD, Takai Shunsuke, MD, Yasuyoshi Morita, MD, PhD, Mitsuhiro Matsuda, MD, PhD, Akihisa Kanamaru, MD, PhD

Blood (2005) 106 (11): 4599.

https://doi.org/10.1182/blood.V106.11.4599.4599

Published: 2005

Journal Articles

Dichotomy of All- Trans Retinoic Acid Inducing Signals for Adult T-Cell Leukemia.

Yasuhiro Maeda, MD, PhD, Terufumi Yamaguchi, MD, PhD, Yasuki Hijikata, MD, Yasuyoshi Morita, MD, PhD, Chikara Hirase, MD, Syunsuke Takai, MD, Jun-ichi Miyatake, MD, PhD, Mitsuhiro Matsuda, MD, PhD, Akihisa Kanamaru, MD, PhD

Blood (2005) 106 (11): 4803.

https://doi.org/10.1182/blood.V106.11.4803.4803

Published: 2005

NARROW

Perioperative Management of Hemophilia a Using Recombinant Factor VIII in Patients Undergoing Major or Minor Surgery

MDS/Secondary AML Associated with Type I Gaucher Disease

Molecular Mechanism for Synergistic Anti-Leukemic Activity of Tyrosine Kinase Inhibitors and Glucocorticoids Against Ph+ALL

BCR-ABL Regulates Death Receptor Expression for TNF-Related Apoptosis-Inducing Ligand (TRAIL) in Philadelphia Chromosome-Positive Leukemia

PD0332991, a CDK4/6 Inhibitor, Has An Anti-Leukemic Activity Against Ph + Leukemia with T315I Mutation in Bcr-Abl; In Vivo Analysis Using Xenograft Mice Model

Discontinuation of Imatinib in Japanese Patients with Chronic Myeloid Leukemia,

Increased NK Cells and Decreased CD3 + CD8 + CD62L + T Cells in CML Patients Who Sustained Complete Molecular Remission After Discontinuation of Imatinib

PD0332991, a CDK4/6 Inhibitor, Has An Anti-Leukemic Activity Against Lymphoid Crisis of CML and Ph+ALL Even with T315I Mutation in BCR-Abl; in Vitro Analysis

Outcome by Treatment Including An Intensified Consolidation Program with Dose-Escalated Doxorubicin for Newly Diagnosed Acute Lymphoblastic Leukemia (ALL): A Study by the Japan Adult Leukemia Study Group (JALSG ALL97 study).

Effects of Anti-Retroviral Drugs to Expression of Cell Surface Adhesion Molecules and Hypermutation of Immunoglobulin Heavy Chain Variable Gene of HIV-Related Lymphoma

Clinical Efficacy of ATRA for Adult T-Cell Leukemia

Possible Eradication of Minimal Residual Disease in Acute Leukemia.

Dichotomy of All- Trans Retinoic Acid Inducing Signals for Adult T-Cell Leukemia.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only